Phenominer Database Results (16 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
F344/NSlc blood glucose level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood glucose amount male 211 days 7 78.0 mg/dl 2.6 6.88 oral glucose tolerance test 0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 12770 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj body weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. body mass male 211 days 11 425.3 g 5.3 17.58 body weighing method 0.0 oral glucose 0 min 12797 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj body weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. body mass male 211 days 11 423.2 g 7.3 24.21 body weighing method 0.0 oral glucose 0 min 12803 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 11 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67478 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj serum leptin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood leptin amount male 211 days 11 5.82 ng/ml 0.59 1.96 enzyme linked immunosorbent assay 0.0 oral glucose 7 days ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67486 311
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj blood glucose level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood glucose amount male 211 days 11 87.7 mg/dl 3.2 10.61 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 12798 311
F344/NSlc serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 7 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67475 311
F344/NSlc serum leptin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood leptin amount male 211 days 7 5.46 ng/ml 1.06 2.8 enzyme linked immunosorbent assay 0.0 oral glucose 7 days ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67483 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj serum leptin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood leptin amount male 211 days 11 6.28 ng/ml 0.51 1.69 enzyme linked immunosorbent assay 0.0 oral glucose 7 days ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67485 311
F344/NSlc body weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. body mass male 211 days 7 393.6 g 6.2 16.4 body weighing method oral glucose 0 min 12785 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj body weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. body mass male 211 days 7 368.7 g 8.7 23.02 body weighing method oral glucose 0 min 12791 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj serum leptin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood leptin amount male 211 days 7 2.8 ng/ml 0.54 1.43 enzyme linked immunosorbent assay 0.0 oral glucose 7 days ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67484 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj blood glucose level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood glucose amount male 211 days 7 78.7 mg/dl 3.4 9.0 oral glucose tolerance test 0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 12786 311
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 7 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67476 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 11 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67477 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj blood glucose level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood glucose amount male 211 days 11 82.5 mg/dl 3.5 11.61 oral glucose tolerance test 0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 12792 311